Buyers searching for a reliable source of Dapoxetine Hydrochloride intermediate (CAS: 129938-20-1) and a trustworthy custom manufacturer for this compound typically face a familiar set of sourcing challenges: extended supply lead times for specialty intermediates, volatile raw material pricing, inconsistent batch quality that interrupts production schedules, and the added cost of coordinating purchases across multiple fragmented suppliers. For procurement and R&D teams, the question is rarely just “where to buy” but “who can supply consistently, with verifiable quality, and with the technical support needed to move from sample to commercial scale.”
Shandong Tianming Pharmaceutical Group, operating under the brand Tianming Pharmaceutical, is positioned to address exactly this type of sourcing need. The group was formally established in 2020, building on its predecessor Shandong Sihuan Pharmaceutical Co., Ltd., founded in 2010. Headquartered in Jinan, Shandong Province, China, the company is recognized as a National High-Tech Enterprise and operates as an R&D-driven pharmaceutical raw material and intermediate enterprise with an integrated R&D-production model. It supplies pharmaceutical intermediates and CMO/CDMO (custom manufacturing organization / contract development and manufacturing organization) custom synthesis solutions to the global pharmaceutical industry.
Dapoxetine Hydrochloride Intermediate in the Product Portfolio
Within Tianming Pharmaceutical’s product matrix, Dapoxetine Hydrochloride intermediate (CAS: 129938-20-1) is listed among the company’s broader intermediate offerings, a category spanning multiple therapeutic and industrial application areas where target customers vary by compound. This reflects the company’s overall strategy: rather than specializing narrowly, Tianming Pharmaceutical maintains a wide product matrix so that customers sourcing niche or specialty compounds can consolidate procurement with a single qualified supplier instead of coordinating across several vendors.
Custom Manufacturing and CDMO Capabilities
For buyers specifically asking about a “custom manufacturer,” Tianming Pharmaceutical’s service model is structured around several offerings: standard intermediate product sales, custom synthesis, process optimization, impurity customization, and new compound development. The service scope extends from pre-sales technical consultation through sample supply at gram-level, hundred-gram, and pilot scale, into custom R&D, process optimization, scale-up, and full commercial supply of intermediates. For international buyers, the company also coordinates logistics, customs clearance, and trade insurance support as part of the order process, alongside after-sales technical support.
This full-stage coverage—laboratory small-batch, pilot scale-up, and commercial production of intermediates—means that a customer evaluating Dapoxetine Hydrochloride intermediate for early-stage formulation work and a customer requiring tonnage-level commercial supply of this intermediate can, in principle, work with the same technical and quality framework rather than transitioning between different suppliers as volume requirements grow.
Quality Assurance Behind Every Batch
A central concern for any custom manufacturing relationship is whether quality can be verified and reproduced batch after batch. Tianming Pharmaceutical runs a quality control system for fine chemical & pharmaceutical intermediate production and maintains ISO9001 Quality Management System Certification, held by Shandong Sihuan Pharmaceutical Co., Ltd. (2025) and Guangxi Tianming Pharmaceutical Co., Ltd. (2024). Complete COA (Certificate of Analysis) and structural confirmation documentation are available for all products in the portfolio, supporting customer-side verification and their subsequent regulatory filing needs.
Full batch traceability is maintained across raw material receipt, reaction parameters, purification processes, and testing data, with all records archived for complete chain-of-custody traceability. This documentation infrastructure is managed through a CRM, ERP, and BPM digital management system that also supports order management, inventory tracking, production scheduling, and customer service coordination—relevant for buyers who need confirmed timelines and transparent order status, particularly across international shipments.
Production Scale and Technical Capacity
Tianming Pharmaceutical’s manufacturing footprint includes three coordinated production bases: Shandong Sihuan Pharmaceutical Co., Ltd. in Dezhou, Shandong; Jining Tianming Pharmaceutical Co., Ltd. in Jining, Shandong; and Guangxi Tianming Pharmaceutical Co., Ltd. in Hechi, Guangxi. Collectively, these sites operate more than 160 reactor vessels, supporting an annual production capacity in the hundreds of tons. The group employs more than 400 people and serves over 2,000 cooperative customers.
This scale matters for custom manufacturing inquiries because it reflects the company’s capacity to handle demand across different order sizes—from gram-level research quantities to larger commercial volumes of intermediates—without the capacity bottlenecks that smaller, single-site suppliers may encounter.
R&D Infrastructure Supporting Reliable Supply
Behind the manufacturing capacity sits a notable R&D commitment. Tianming Pharmaceutical operates two R&D centers—Shandong Tianming Pharmaceutical Technology Co., Ltd. in Jinan and Nanjing Tianming Pharmaceutical Technology Co., Ltd. in Nanjing—with a combined laboratory area exceeding 6,000 square meters and an R&D team of more than 100 personnel. The company directs more than 10% of annual revenue to R&D innovation, with an additional 1% allocated to management system iteration. Testing infrastructure includes over RMB 40 million in equipment such as HPLC, gas chromatography, mass spectrometry, LC-MS, and chiral analysis instruments, managed under an IPD (integrated product development) system. The group also holds 20 invention patents and 40 utility model patents.
For a custom manufacturer evaluation, this technical base is relevant because process development, impurity profiling, and route optimization for intermediates like Dapoxetine Hydrochloride intermediate depend on exactly this kind of analytical and development infrastructure.
Delivery Timelines and Service Assurance
On the practical question of timing, Tianming Pharmaceutical states that in-stock intermediate orders are delivered within 7–15 working days, covering order confirmation, quality review, packaging, and shipping. Made-to-order lead times depend on synthesis complexity, workshop scheduling, and raw material availability, with expedited production scheduling available for urgent projects.
Customer support follows a 1-on-1 account manager plus technical engineer dual support model. Routine technical questions are addressed with reference solutions within 2 hours, while more complex technical issues are resolved with a written report within 24 hours. Periodic follow-up visits and on-site technical support are available for bulk and framework cooperation customers.
Global Reach for International Buyers
Tianming Pharmaceutical’s business coverage extends beyond China to more than 30 countries and regions across South Asia, Southeast Asia, the Middle East, Central and South America, and Africa, supported by overseas business entities in India and Bangladesh. Shipping options include air freight, sea freight, and express courier, with cold chain handling available for temperature-sensitive products and nitrogen-filled vacuum packaging for oxidation-sensitive materials. Every order includes transport insurance, with compensation and free replacement available for transport-related quality damage caused by transit.
For procurement teams asking where to buy Dapoxetine Hydrochloride intermediate from a qualified custom manufacturer, these combined elements—documented quality control systems for intermediates, multi-site production scale, dedicated R&D infrastructure, defined delivery timelines, and international logistics support—form the practical basis on which Shandong Tianming Pharmaceutical Group positions itself to serve both research-stage and commercial-stage intermediate sourcing requirements.
Disclaimer: This is a pharmaceutical intermediate for R&D use only, not an API. Not for clinical or human use. Downstream regulatory compliance is the responsibility of the purchaser.
Tianming Pharmaceutical Group
